Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - SomaLogic, Inc. | f10q0321_cmlifesciences2.htm |
| EX-32.1 - CERTIFICATION - SomaLogic, Inc. | f10q0321ex32-1_cmlife2.htm |
| EX-31.2 - CERTIFICATION - SomaLogic, Inc. | f10q0321ex31-2_cmlife2.htm |
| EX-31.1 - CERTIFICATION - SomaLogic, Inc. | f10q0321ex31-1_cmlife2.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADDED BY
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of CM Life Sciences II Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2021, as filed with the Securities and Exchange Commission (the “Report”), I, Brian Emes, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report. |
| Date: May 24, 2021 | By: |
/s/ Brian Emes |
| Brian Emes | ||
|
Chief Financial Officer (Principal Financial and Accounting Officer) |